GelMA microneedle-loaded bio-derived nanovaccine shows therapeutic potential for gliomas
Glioma is the most common primary malignant tumor of the central nervous system in adults. Although immunotherapy, especially tumor vaccines, has made some progress in the treatment of gliomas compared with surgery and radiotherapy. However, the lack of specific or relevant tumor antigens severely l...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Taylor & Francis Group
2024-12-01
|
| Rangatū: | Science and Technology of Advanced Materials |
| Ngā marau: | |
| Urunga tuihono: | https://www.tandfonline.com/doi/10.1080/14686996.2024.2426444 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|